V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10320375 | 10056242 | null | null | Neo-adjuvant (N) | 2019-07-11 | 2019-08-23 | CHLORAMBUCIL + OBINUTUZUMAB | null | N | CHLORAMBUCIL + OBINUTUZUMAB | 100959756 |
| 10320429 | 10056243 | 1.62 | 113.2 | Palliative (P) | 2018-03-28 | 2018-03-28 | Carboplatin + Vinorelbine IV &PO D8 | 02 | N | CARBOPLATIN + VINORELBINE | 100872545 |
| 10320457 | 10056244 | 1.58 | 56.5 | 03 | 2019-05-30 | 2019-05-30 | CABOZANTINIB | 2 | N | CAPECITABINE + IRINOTECAN | 101694398 |
| 10320532 | 10056245 | 1.68 | 98 | Palliative (P) | 2018-02-13 | 2018-05-07 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101819757 |
| 10320539 | 10056246 | 1.82 | 62.7 | Palliative (P) | null | 2018-03-01 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 101278101 |
| 10320589 | 10056247 | null | null | null | 2021-04-15 | 2021-04-20 | Cabazitaxel | null | null | CABAZITAXEL | 100783916 |
| 10320620 | 10056248 | null | 73.8 | Palliative (P) | 2019-11-25 | 2019-12-05 | MELPHALAN | 02 | N | MELPHALAN | 100436240 |
| 10320668 | 10056249 | 1.85 | 82.3 | null | 2019-10-15 | 2019-10-26 | Bortezomib + Cyclophos + Dex | 2 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100475708 |
| 10320674 | 10056250 | 1.75 | 89.3 | Neo-adjuvant (N) | 2020-04-17 | 2020-05-22 | FLUOROURACIL | 02 | N | DABRAFENIB | 101130146 |
| 10320703 | 10056251 | 1.66 | 74.7 | Palliative (P) | 2019-04-27 | 2019-11-15 | DABRAFENIB | 02 | N | ACALABRUTINIB | 101179052 |
| 10320797 | 10056252 | 1.77 | 69 | Adjuvant (A) | 2022-04-20 | 2022-05-18 | Melphalan IV High dose | 02 | N | MELPHALAN | 101456180 |
| 10320884 | 10056254 | 1.85 | 84.2 | null | null | 2019-12-09 | Busulfan Oral | 02 | null | VINORELBINE | 101153253 |
| 10321197 | 10056257 | null | null | 03 | 2021-11-05 | 2021-11-05 | Niraparib | null | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100954496 |
| 10321407 | 10056259 | 1.84 | 84.1 | Palliative (P) | 2021-04-18 | 2021-07-17 | Cisplatin + Vinorelbine (IV) | 02 | N | IPILIMUMAB + NIVOLUMAB | 100229227 |
| 10321661 | 10056260 | 1.7 | 92.2 | Palliative (P) | 2020-10-31 | 2020-11-24 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100687840 |
| 10321702 | 10056261 | null | null | null | null | 2018-09-02 | Azacitidine | null | null | AZACITIDINE | 100664964 |
| 10321713 | 10056262 | 1.67 | 66.4 | Palliative (P) | null | 2019-08-24 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101191639 |
| 10321748 | 10056263 | 1.7 | 72 | Adjuvant (A) | 2018-05-06 | 2018-05-20 | Cisplatin + Vinorelbine (PO) | 02 | N | ACALABRUTINIB | 100699637 |
| 10322030 | 10056264 | 1.64 | 83 | null | null | 2021-03-12 | GEMCITABINE + RT | 02 | null | GEMCITABINE | 100642397 |
| 10322130 | 10056266 | 1.61 | 49.9 | Palliative (P) | 2019-01-13 | 2019-01-13 | Cisplatin | 02 | Y | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100330941 |
| 10322281 | 10056267 | 1.67 | 57 | Palliative (P) | null | 2017-11-19 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101070096 |
| 10322347 | 10056268 | null | 102 | null | 2020-07-03 | 2020-07-11 | Chlorambucil | 02 | null | CHLORAMBUCIL | 100321544 |
| 10322573 | 10056270 | 1.77 | 90 | Palliative (P) | 2018-07-27 | 2018-08-24 | Carboplatin + Liposomal Doxorubicin | 02 | N | BUSULFAN | 101258980 |
| 10322578 | 10056271 | null | 69.5 | 03 | 2018-11-07 | 2018-11-07 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100248871 |
| 10322592 | 10056272 | 1.7 | 66.2 | 03 | 2018-06-18 | 2019-03-25 | null | 02 | N | CABOZANTINIB | 101522222 |
| 10322747 | 10056274 | null | null | Disease modification (D) | 2018-11-11 | 2018-12-01 | Bortezomib + Panobinostat | null | N | BORTEZOMIB + PANOBINOSTAT | 100560567 |
| 10322806 | 10056275 | null | null | Neo-adjuvant (N) | null | 2016-04-13 | BORTEZOMIB + THALIDOMIDE | null | N | DABRAFENIB | 100070307 |
| 10323004 | 10056277 | 1.69 | 124 | Palliative (P) | 2019-02-09 | 2019-02-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100673972 |
| 10323051 | 10056278 | 1.83 | 76 | Palliative (P) | 2017-02-22 | 2017-03-04 | Cisplatin 7 day | 02 | N | NIRAPARIB | 101703004 |
| 10323152 | 10056280 | 1.69 | 85.3 | Curative (C) | 2016-07-29 | 2016-08-13 | DABRAFENIB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100164694 |
| 10323436 | 10056281 | 1.68 | 70.3 | Curative (C) | 2019-03-12 | 2019-03-22 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | CYCLOPHOSPHAMIDE | 101001183 |
| 10323478 | 10056282 | 1.63 | 84.9 | Palliative (P) | 2017-10-28 | 2017-11-18 | CISPLATIN + GEMCITABINE | 02 | N | FLUOROURACIL | 101080308 |
| 10323770 | 10056283 | null | null | Palliative (P) | 2018-05-01 | 2018-05-26 | Cisplatin + Vinorelbine (PO) | N | N | CISPLATIN | 101825349 |
| 10323806 | 10056284 | null | null | null | 2017-10-14 | 2017-10-29 | Methotrexate intrathecal | null | null | METHOTREXATE | 100110497 |
| 10324034 | 10056285 | 1.75 | 70 | null | 2020-06-21 | 2020-06-21 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 100378987 |
| 10324065 | 10056286 | 1.58 | 57.4 | null | 2021-09-25 | 2022-01-11 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101110343 |
| 10324228 | 10056287 | 1.69 | 85 | null | 2019-09-25 | 2019-12-28 | Niraparib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101693794 |
| 10324344 | 10056288 | 1.85 | 91.4 | 03 | 2019-03-16 | 2019-03-16 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100453548 |
| 10324364 | 10056289 | 1.58 | 76.4 | Adjuvant (A) | 2020-07-03 | 2020-07-09 | CVP R | 02 | N | DABRAFENIB | 101315967 |
| 10324397 | 10056290 | 1.58 | 61.4 | null | 2007-06-04 | 2017-06-21 | Cabazitaxel | 02 | null | CABAZITAXEL | 101632972 |
| 10324586 | 10056292 | 1.71 | 111.8 | Palliative (P) | null | 2019-11-20 | Carboplatin + Vinorelbine IV &PO D8 | 02 | N | CARBOPLATIN + VINORELBINE | 100475241 |
| 10324734 | 10056294 | 1.79 | 80.7 | Palliative (P) | 2019-01-24 | 2019-02-11 | Cabazitaxel | 02 | N | CABAZITAXEL | 100496987 |
| 10324762 | 10056295 | 1.74 | 0 | Palliative (P) | 2021-08-26 | 2021-09-23 | Cabazitaxel | 02 | N | CABAZITAXEL | 100311553 |
| 10324771 | 10056296 | 1.56 | 82.6 | null | 2019-06-27 | 2019-07-04 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100514049 |
| 10324828 | 10056297 | null | 78 | Palliative (P) | 2021-09-16 | 2021-09-30 | Fluorouricil + Folonic Acid (MdG) | 02 | N | CABOZANTINIB | 100499158 |
| 10324881 | 10056299 | 1.64 | null | Palliative (P) | 2015-09-03 | 2017-02-17 | METHOTREXATE | null | N | METHOTREXATE | 101724138 |
| 10324882 | 10056300 | 1.66 | 61.3 | null | 2021-12-26 | 2022-01-10 | AFATINIB | 02 | null | AFATINIB | 100530100 |
| 10324889 | 10056301 | 1.61 | 73.1 | 03 | null | 2022-01-12 | AFATINIB | 02 | N | AFATINIB | 101262419 |
| 10324922 | 10056302 | 1.65 | 68.8 | Palliative (P) | null | 2020-01-01 | null | null | N | CAPECITABINE + IRINOTECAN | 101164458 |
| 10324935 | 10056303 | null | 52.5 | 03 | null | 2019-03-27 | PERTUZUMAB + TRASTUZUMAB | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101175091 |